Stay updated on Merck & Co. Press Releases

Sign up to get notified when there's something new on the Merck & Co. Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Merck & Co. Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    New items highlight recent KEYTRUDA data and Merck investments (e.g., Elkton center), signaling a shift toward showcasing ongoing clinical breakthroughs and infrastructure growth; older dated items about acquisitions and conference calls have been removed.
    Difference
    87%
    Check dated 2025-10-21T01:38:16.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Major updates add new 2025 milestones (data at European AIDS Conference, ESMO 2025, Verona Pharma acquisition) and remove several September 2025 trials/news; page now emphasizes newer corporate activities and timing.
    Difference
    81%
    Check dated 2025-10-13T20:59:24.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Significant updates: new clinical development program initiation (Phase 2b) and a notable Phase 3 trial result, plus upcoming earnings call details. Some older conference participation notices have been removed. Overall, the page now emphasizes current trial activity and corporate events over past conference appearances.
    Difference
    85%
    Check dated 2025-10-06T15:58:07.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Adds new product approvals, regulatory milestones, and a Breakthrough Therapy designation for Merck, including KEYTRUDA subcutaneous use and ENFLONSIA/RSV news, while removing older related items. The page now emphasizes newer, high-impact regulatory updates.
    Difference
    81%
    Check dated 2025-09-22T05:28:48.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page adds two biotech news items and removes two financial updates, signaling a focus shift toward health/biotech content. Specifically, CAPVAXIVE vaccine results and Ifinatamab Deruxtecan Breakthrough Therapy news are added, while Merck Q2 results and a dividend announcement are removed.
    Difference
    80%
    Check dated 2025-09-14T23:45:44.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The webpage has updated its content to reflect new clinical trial results and corporate participation in upcoming events, while removing older news releases and updates.
    Difference
    86%
    Check dated 2025-09-07T20:29:18.000Z thumbnail image

Stay in the know with updates to Merck & Co. Press Releases

Enter your email address, and we'll notify you when there's something new on the Merck & Co. Press Releases page.